These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34489165)

  • 21. Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology.
    Murakami T; Yabe D; Inagaki N
    J Diabetes Investig; 2019 Sep; 10(5):1168-1170. PubMed ID: 30989811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bullous pemphigoid with linear lesions and antibodies exclusively against the soluble ectodomain of BP180 (LAD-1).
    Mahmoudi H; Toosi R; Kamyab K; Zillikens D; Schmidt E; Daneshpazhooh M
    J Dtsch Dermatol Ges; 2019 Sep; 17(9):933-935. PubMed ID: 31353797
    [No Abstract]   [Full Text] [Related]  

  • 23. Dipeptidyl Peptidase-4 Inhibitor Induced Bullous Pemphigoid Complicated by Acquired Reactive Perforating Dermatosis.
    Gambichler T; Espey B; Doerler M; Stranzenbach R
    Actas Dermosifiliogr; 2022 Oct; 113(9):914-915. PubMed ID: 35636509
    [No Abstract]   [Full Text] [Related]  

  • 24. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
    Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
    [No Abstract]   [Full Text] [Related]  

  • 25. Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII.
    Zimina EP; Hofmann SC; Fritsch A; Kern JS; Sitaru C; Bruckner-Tuderman L
    J Invest Dermatol; 2008 Nov; 128(11):2736-2739. PubMed ID: 18548115
    [No Abstract]   [Full Text] [Related]  

  • 26. Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Kayaba H; Sawamura D
    J Dermatol; 2020 Jan; 47(1):e25-e26. PubMed ID: 31646656
    [No Abstract]   [Full Text] [Related]  

  • 27. Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium.
    Gutjahr A; Heck F; Emtenani S; Hammers AK; Hundt JE; Muck P; Siegel DL; Schmidt E; Stanley JR; Zillikens D; Hammers CM
    Br J Dermatol; 2019 Sep; 181(3):593-594. PubMed ID: 31124130
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE.
    Salz M; Haeberle S; Hoffmann J; Enk AH; Hadaschik EN
    J Dermatol Sci; 2017 Sep; 87(3):309-311. PubMed ID: 28823642
    [No Abstract]   [Full Text] [Related]  

  • 29. Gliptin-associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4/CD26 in Bullous Pemphigoid.
    Lindgren O; Varpuluoma O; Tuusa J; Ilonen J; Huilaja L; Kokkonen N; Tasanen K
    Acta Derm Venereol; 2019 May; 99(6):602-609. PubMed ID: 30848289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
    Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
    J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies.
    Kasprick A; Holtsche MM; Rose EL; Hussain S; Schmidt E; Petersen F; Panicker S; Ludwig RJ
    J Invest Dermatol; 2018 Feb; 138(2):458-461. PubMed ID: 28899686
    [No Abstract]   [Full Text] [Related]  

  • 32. Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid efficiently treated with omalizumab.
    Garrido PM; Alexandre MI; Travassos AR; Filipe P
    Dermatol Ther; 2020 Nov; 33(6):e14160. PubMed ID: 32770711
    [No Abstract]   [Full Text] [Related]  

  • 33. Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
    Kusajima E; Akiyama M; Sato M; Natsuga K; Shimizu H
    Int J Dermatol; 2011 Feb; 50(2):238-40. PubMed ID: 21244398
    [No Abstract]   [Full Text] [Related]  

  • 34. Case of papuloerythroderma of Ofuji-like eruption during the course of bullous pemphigoid.
    Hayakawa-Asai R; Nobeyama Y; Maki T; Asahina A; Nakagawa H
    J Dermatol; 2018 Mar; 45(3):e63-e64. PubMed ID: 29205461
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
    Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
    J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
    [No Abstract]   [Full Text] [Related]  

  • 36. A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors.
    Izumi K; Nishie W; Beniko M; Shimizu H
    Front Immunol; 2019; 10():1439. PubMed ID: 31297116
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.
    Nakama K; Koga H; Ishii N; Ohata C; Hashimoto T; Nakama T
    JAMA Dermatol; 2018 Mar; 154(3):347-350. PubMed ID: 29299596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
    Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
    Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris.
    Inokuma D; Kodama K; Natsuga K; Kasai M; Abe M; Nishie W; Abe R; Hashimoto T; Shimizu H
    Br J Dermatol; 2009 Feb; 160(2):451-4. PubMed ID: 19077079
    [No Abstract]   [Full Text] [Related]  

  • 40. Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three cases.
    Fania L; Didona D; Pacifico V; Mariotti F; De Luca N; Abeni D; Mazzanti C; Di Zenzo G; Didona B
    J Dermatol; 2018 Sep; 45(9):1135-1140. PubMed ID: 30007013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.